Do Triangle Petroleum Corporation (TPLM) and StemCells Inc (STEM) Have Long Term Potential?

Posted by admin March 18, 2015 0 Comment 996 views

New York, NY – GDP INSIDER  –  03/18/2015.

This article discusses three companies: Triangle Petroleum Corporation (NYSEMKT:TPLM) and StemCells Inc (NASDAQ:STEM)

Triangle Petroleum Corporation (NYSEMKT:TPLM) continued to decline yesterday with the stock dropping 3.48% or $0.17 to close at $4.72, with more than 2.166 million shares changing hands compared to its three month average trading volume of 1.859 million. The oil and natural gas exploration and development company has been seeing its stock value decline recently, in line with the ongoing weakness in the price of oil. Triangle Petroleum Corporation has been underperforming for the last six months, with the stock down 59.72% compared to the S&P 500 which is up 3.62% over the same period. The difference has narrowed since the beginning of the year, with the stock down only 1.26% while the S&P 500 is up 0.74%. With quarterly revenue growth of 96.70% and diluted EPS of $0.70 the stock has potential for growth, but that will largely be dependent on whether oil prices go up again. Better to sell than hold for now.

Does Triangle Petroleum Corporation Have The Fundamentals To Bounce Back? Take A Closer Look With Free TPLM Analysis.

StemCells Inc (NASDAQ:STEM) continued to decline yesterday closing down 11.29% or $0.14 at $1.10 on heavy trading volume of 1.519 million shares, compared to its three month average trading volume of 0.583 million. The clinical research and development company started to fall on Monday when it announced its fourth quarter and full year financial results, which showed a loss of $10.2 million for Q4, compared to a loss of $6.9 million for the same period last year. Overall, StemCells Inc lost $32.7 million or $0.53 per share for the year even though revenue was up at $1.012 million compared to $0.172 in 2013. Despite the lower than expected financial results, the stock has been performing well so far this year with its share price up 17.14%. With a one year target estimate of $5.45 and RSI of 44.23, there is plenty of potential for the stock to become a solid medium to long term investment.

What Does StemCells Inc’s Financial Report Mean For The Long Term? Delve Into The Details With Free STEM Analysis.

About UltimateStockAlerts provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word ULTIMATE to 555888 from your cell phone.

UltimateStockAlerts continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.

Disclosure:  UltimateStockAlerts is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit website, for complete risks and disclosures.

Write Your Comment